Financials
Financial year 2025
NITYA from Ukkel, company number BE1019934214, closed financial year 2025 with a result of € -83,361 after tax. For that financial year NITYA recorded a gross margin of € 30,151 and equity of € 16,639. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 16,639
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -83,361
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € -83,361.
People and assets in 2025
€ 5,816
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 10.2 million
Loans from banks and other lenders, long and short.
€ 2,662
Supplier invoices still open on the last day of the fiscal year.
€ 27,744
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to NITYA?
What happened at NITYA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- HETAFIN SRL became a director. NBB
- New annual accounts for financial year 2025: loss of € 83,361. filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- CLINIMETRICS SA became a director. NBB
- CELINE BUYSE became a director. NBB
A new publication or filing at NITYA? We notify you, reason included.
Follow NITYADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of CLINIMETRICS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
NITYABehind NITYA are CLINIMETRICS SA, CELINE BUYSE and HETAFIN SRL. The shares are held by CLINIMETRICS (25%).
Directors
According to the 2025 annual accounts
Director
Also active at: INTERNATIONAL DRUG DEVELOPMENT INSTITUTE, Bright Roads, C3M3, One2Treat, CluePoints
since 2025
CELINE BUYSE
Director
since 2025
since 2027
Shareholders
25%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Waterloosesteenweg 1139
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1019.934.214
- VAT number
- BE 1019.934.214
- Registered office
- Waterloosesteenweg 1139, 1180 Ukkel
- Names & denominations
- NITYA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 February 2025
- Peppol
- Active · Active since 16 Apr 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten van holdings